106
Views
0
CrossRef citations to date
0
Altmetric
Retina and Choroid

Cutaneous melanin and glaucoma: a case control study

, , , , , , , & ORCID Icon show all
Pages 1428-1431 | Received 02 Jun 2020, Accepted 02 Feb 2021, Published online: 22 Feb 2021
 

ABSTRACT

Purpose: Previous studies have used subjective assessments to implicate darker skin color as a risk factor for glaucoma. This study used objective measurements to determine whether skin melanin is a risk factor for glaucoma.

Methods: In a case-control study conducted at a tertiary eye hospital in Nepal, patients aged 40 years or older from the glaucoma clinic were enrolled as cases and age-matched patients without glaucoma from other clinics at the eye hospital were enrolled as controls. A colorimeter was used to capture melanin measurements in triplicate from the inner arm and forehead of each participant. The exposure variable of interest was the median skin melanin value, in arbitrary units. The outcome of interest was the presence of glaucoma.

Results: 100 glaucoma cases and 100 matched controls were enrolled. Agreement between the triplicate melanin measurements was high, with an intra-class correlation of 0.99 (95% CI, 0.99–0.99) for inner arm measurements and 0.97 (95% CI 0.96–0.98) for forehead measurements. Mean inner arm melanin values were 604 units (standard deviation [SD] 177) in cases and 602 units (SD 179) in controls; forehead values were 650 (SD 146) in cases and 652 (SD 152) in controls. After adjusting for sex and country of residence, skin melanin was not associated with the presence of glaucoma (odds ratio 1.04, 95%CI 0.78–1.38 for inner arm values and 0.97, 95%CI 0.70–1.35 for forehead values).

Conclusion: This study failed to find a significant association between skin pigmentation and glaucoma.

Acknowledgments

None

Declaration of interest

None of the authors discloses a conflict of interest.

Additional information

Funding

This work was supported by the That Man May See [None]; Fortisure Foundation [None]; Research to Prevent Blindness [None].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.